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This is the ﬁrst case description of the association of Klippel-Feil Syndrome (KFS), Tourette Syndrome (TS), Motor Stereotypies,
and Obsessive Compulsive Behavior, with chromosome 22q11.2 Duplication Syndrome (22q11DupS). Neuropsychiatric
symptoms in persons with 22q11.2 deletion, including obsessive compulsiveness, anxiety, hyperactivity, and one prior case report
of TS, have been attributed to low copy number eﬀects on Catechol-O-Methyltransferase (COMT). However, the present unique
case of 22q11DupS and TS suggests a more complex relationship, either for low- or high-COMT activity, or for other genes at this
locus.
Copyright © 2009 Raymond A. Clarke et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Klippel-Feil Syndrome (KFS) involves a congenital fusion
of vertebrae in the cervical spine [1]. Tourette Syndrome
(TS) is a heritable neuropsychiatric disorder characterized
by persistent, childhood-onset tics that ﬂuctuate in intensity,
migrate in anatomic location, and are performed in response
tosensoryurges[2].Motorstereotypiesusuallyhaveyounger
onset, are much more stable phenomenologically, and
occur involuntarily with excitement or other stimulation
[3]. Longstanding clinical observations that high doses
of amphetamines can induce stereotypies and tics [4],
while dopamine receptor blocking agents inhibit them [5],
supportahyperdopaminergicneurotransmissionorreceptor
hypersensitivity model for these symptoms, although the
dopamine/tic relationship is likely much more complex
[6].
Large genetic association and linkage studies to date
have failed to implicate genes for dopamine synthesis or
metabolism as causes of TS, but clinical presentations
of rare genetic diseases involving dopamine pathways are
supportive, as in a recently reported case of TS in a girl
with chromosome 22q11 deletion [7]. This region contains
Catechol-O-Methyltransferase (COMT), which degrades
dopamine, norepinephrine, and epinephrine. Low-COMT
gene copy number has been associated with obsessive com-
pulsive and hyperactive psychopathology in velocardiofacial
syndrome [8], and lesser-COMT activity theoretically could
increase catecholamines and hyperkinetic movements.
Wereportclinicalandgeneticcharacterizationoftheﬁrst
case of 22q11DupS and TS, KFS, and stereotypies, suggesting
that both low and high copy numbers of 22q11 may generate
hyperkinetic and obsessive compulsive symptoms.
2. Case Presentation
The patient, a Caucasian male diagnosed with KFS, was
referred at age of 9 years for evaluation of repetitive move-
ments. He presented with motor stereotypy in the 1st year
of life which persists to the present: a patterned movement
involving the ﬂapping of both hands, and sometimes body
and leg stiﬀening is occurring daily, with excitement. From
age 6 to his present age, 12 years, he has had a series of
mild tics including eye blinking, nose twitching, leg and toe
pointing, and repetitive coughing and sniﬃng, consistent2 Case Reports in Medicine
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Figure 1: Computed Tomography of the C Spine, with 3D recon-
struction, showing Klippel-Feil anomaly comprising of the fusion
of multiple cervical and upper thoracic vertebrae.
with a diagnosis of TS. He also has obsessive compulsive
behaviour (OCB) and anxiety, with excessive rumination,
but no Attention Deﬁcit Hyperactivity Disorder (ADHD).
He has seen a psychologist for dysthymia and adjustment but
takes no neurologic or psychiatric medications. At school,
academic performance is average to above. Past Medical
History includes full-term birth, at 3.1kg. Development
includes walking by 16 months and speaking normally by
2 years. Surgical history includes a Woodward Procedure
for Sprengel’s Deformity of the scapula and Cervical Spine
DecompressionandStabilization.Reviewofsystemsincludes
parasomnias and migraines. Family history is negative for
tics, OCB, or other neurologic or psychiatric disorders.
General examination revealed a barrel-chested appear-
ance, a short neck with low posterior hairline, abnormal
scapulae, and webbing of toes. At age of 12 years, weight
was 36.6kg (75%ile), height was 126.4cm (<5%ile), body
mass index was 34 (>95%ile), and head circumference was
50.5cm. Palate and cardiac exams were normal. Neurologic
exam was notable for normal language and gregarious
social interactions. Occasional tics and the stereotypy were
observed. Cranial nerve exam was normal. Distal strength
was diminished in both hands and thumb abductors.
Reﬂexes were 2+ and symmetric. Fine movements of the
hands were clumsy and slow. Sensation was diminished to
light touch in the hands. Current clinical ratings showed Yale
Global Tic Severity Scale (YGTSS) total tic score of 6 (mild),
Child Yale-Brown Obsessive Compulsive Scale (CY-BOCS)
score of 16 (mild/moderate), and the DuPaul ADHD Rating
Scale (ADHDRS) score of 17 (subthreshold).
Imaging studies include CT scans that revealed fusion
of cervical and thoracic vertebrae (Figure 1), scoliosis,
hypoplastic thumbs, and several digits of the feet and hands.
Duetothecomplexphenotype,weevaluatedthepatient’s
DNA using comparative genomic hybridization (CGH)
analysis (BeadChip technology with a Single Nucleotide
Polymorphism based array; Illumina HD Human610-quad
BeadChip platform). This revealed a ∼3Mb hemizygous
microduplication of chromosome 22q11.2, the same region
as the classical 22q11 microdeletion syndrome [9], as well
as the 22q11.2 duplication with a less well-characterized
phenotype [10]. This region contains genes coding for
approximately 20 proteins expressed in brain and/or bone.
Followup negative testing of the parents demonstrated
that this duplication was de novo.
To further characterize this boy’s COMT genotype,
we generated a lymphocyte cell line. DNA nucleotide
sequence analysis indicated that the patient was heterozy-
gous for the G675A COMT haplotype (Figure 2(a)i) and
that the chromatogram peak height for the 675G variant
was consistently two times higher than that of the 675A
variant (Figure 2(a)i). This suggests that the 675G (higher-
expressing) allele [11] was duplicated. We then compared
mRNA/cDNA sequence for the patient and a normal indi-
vidual. The G:A ratio for the normal control heterozygote
was slightly >1( Figure 2(a)iii) consistent with the instability
ofthe675AmRNAtranscript[11].Incontrast,theG:Aratio
for the patient was >2( Figure 2(a)ii) which again suggested
that the patient has a higher than normal level of expression
of the COMT gene.
To directly compare COMT gene expression levels,
we optimized a proven two-step, high-temperature, semi-
quantitative RTPCR protocol (denature at 94◦Cf o r3 0
seconds followed by extension at 71◦C for 40 seconds
for 33 cycles) [12] using primers speciﬁc for either the
675G or 675A: the forward 675G primer (COMT-ValF 5 -
ATGGTGGATTTCGCTGGCGT-3 ) and the 675A primer
(COMT-MetF 5 -ATGGTGGATTTCGCTGGCAT-3 )w e r e
positioned within exon 4 of the COMT gene, and the reverse
primer (COMT-R 5 -CTTCCGCAGCAGGCCACATT-3 )
was positioned in exon 5. Only the patient (Figure 2(b),l a n e
2) expressed the 675A allele and both the patient and two
normal controls (lanes 3 and 4) had comparable levels of
expression of the 675G allele, as evident from the agarose gel
electrophoresis of the amplicons.
To assess possible clinical implications of this ﬁnding,
cerebrospinal ﬂuid was obtained via lumbar puncture for
assessment of neurotransmitter levels. Routine cells (1 white,
1 red blood cell), protein, and glucose were normal. Levels
of CSF neurotransmitter metabolites were obtained through
HPLCtestingcommercially(MedicalNeurogenetics,Atlanta,
Georgia). The level of 3-O-methyldopa, a metabolite of L
DOPA via COMT, was normal at 19nmol/L (normal <100).
The level of Homovanillic acid, a ﬁnal common pathway
metabolite of dopamine and norepinephrine via COMT, was
normal at 279nmol/L (167–563).
3. Discussion
We describe a boy with KFS, TS, stereotypy, and obses-
sive compulsive symptoms in association with de novo
22q11DupS with normal parental. This is the ﬁrst reportCase Reports in Medicine 3
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Figure 2: (a) Nucleotide sequence chromatograms across the COMT G675A haplotype using (i) patient DNA, (ii) patient cDNA, (iii)
mRNA/cDNA from a normal control heterozygote. (b) Expression of the COMT G675A variants. COMT amplicons from semiquantitative
RT-PCR were visualized on an agarose gel after 33 cycles using β2-actin and GAPDH (housekeeping genes) as the quantitation control. Lane
1—no cDNA control, lane 2—patient, lane 3 & 4—normal control individuals that were homozygous for the 675G allele.
of TS associated with 22q11DupS. The incidence of TS in
the general population is suﬃciently high that this associ-
ation could be incidental. However, a 22q11.2 deletion has
been reported in association with tics and TS [7], and as
neither parent had a personal or family history of these
neuropsychiatric symptoms, our results suggest that the
22q11DupS may confer risk for the TS phenotype.
Hemizygous microdeletion at 22q11.2 (22q11DS) is the
most common microdeletion syndrome, usually involving
homologousrecombinationofthesame ∼3Mbregiondupli-
cated in our patient [13]. Within the 22q11.2 duplication
region, candidate genes implicated in central nervous system
structure or function include CLTCL1, RTN4R, SNAP29,
PRODH, GSCL, UFDIL, ES2, and COMT. The COMT gene
(MIM no. 116790) has particular interest because of its
role in monoamine degradation and because a common
675G >A (Val158Met) substitution results in the dysreg-
ulation of the dopaminergic system. The 675A allele of
the COMT haplotype codes for the 158Met variant of this
membrane-bound enzyme that is expressed at lower levels
in the brain compared to the alternate 158Val variant [14].
A recent investigation of 126 normal healthy Caucasian
subjects indicated the COMT low-expression/low-activity A
allele forms part of a more expansive COMT gene haplotype
“G-A-A” that appears to associate with ineﬃcient prefrontal
working-memory response [15]. This same COMT haplo-
type (G-A-A) also appears to be more prevalent in 22q11DS
patients with OCD and ADHD [16].
Both low copy number in 22q11DS and reduced COMT
expression due to the presence of a COMT 675A allele
[14] have been associated with neuropsychiatric symptoms,
including anxiety and Obsessive Compulsive Symptoms [17,
18]. Cerebrospinal ﬂuid neurotransmitter and metabolite
levels were not altered in our patient. Although this ﬁnding
mighthavehadtreatmentimplications,itwasnotsurprising.
A recent report showed no alterations in these studies in
psychiatric patients with COMT gene polymorphisms [19].
Another study found CSF dopamine changes in Restless4 Case Reports in Medicine
Legs Syndrome, but mainly in the presence of more severe
symptoms [20]; our patient has milder motor tic symptoms.
Finally, it is worth pointing out that studies have questioned
the role for low COMT activity in psychiatric disorders
[21,22].OurpatientwasheterozygousfortheG675ACOMT
haplotype with duplication or the 675G, higher-expressing
COMT allele. As such, the 22q11.2 duplication for this
patient calls into question a unique role of low COMT
activity in the etiopathogenesis of OCD or TS.
Outsidethebrain,the22q11DSand22q11DupSmanifest
considerable phenotypic overlap, including congenital heart
defects, palatal defects and abnormal facies, micrognathia,
short stature, dysplastic ears and hearing defects, down-
slanting palpebral ﬁssures, urogenital anomalies, absent
thymus, T cell deﬁciency, anomalies of the hands and feet,
and scoliosis, suggesting diverse eﬀects of both low and
high copy numbers [23]. Mouse studies indicate that many
of the physical anomalies associated with copy number
variation at 22q11.2 are attributable to Tbx1 dosage [24].
Mutations in the GDF6 gene, which is expressed in the
developing intervertebral space, are causative for the KF2
classofKFS[25].Tbx1islikewiseexpressedinthedeveloping
intervertebral space [25, 26]. The 22q11DS has shown prior
association with synostosis in the appendages, scoliosis,
and vertebral irregularities [9]; however, this is the ﬁrst
report of vertebral fusion in association with duplication or
deletion at 22q11.2. We propose Tbx1 as a candidate gene
for broad spectrum KFS where it presents in association
withSprengle’sshoulder,heart,andpalataland/orurogenital
anomalies.
4. Conclusion
This study is the ﬁrst to report an association between
TS and 22q11DupS, thereby broadening the link between
copy number variation at 22q11.2 and the development
of TS and comorbid neurobehavioral disorders including
OCB. Further research should delineate the basis for linkage
betweenoneormoregeneswithinthe22q11.2∼3Mbcritical
recombination region and neuropsychiatric disorders.
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